Welsis (WLSS) Operating Margin (2022 - 2023)
Welsis' quarterly Operating Margin came in at 613.25% in Q4 2023, down 35008.0% year-on-year from N/an in Q4 2022, and down 22277.28% quarter-over-quarter from 2.77% in Q3 2023.
Welsis has reported Operating Margin for 2 years, with the latest figure at 613.25% in Q4 2023.
- For the quarter ending Q4 2023, Operating Margin fell 35008.0% year-over-year to 613.25%; the trailing twelve-month figure through Sep 2024 stood at 2894.9% (down 277170.0% YoY), and the FY2024 full-year result was 2894.9%, down 277493.0% from the prior year.
- Operating Margin for Q4 2023 stood at 613.25%, down from 2.77% in the prior quarter.
- The five-year high for Operating Margin was 2.77% in Q3 2023, with the low at 613.25% in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 29.41% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 3.36% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 29.03% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 17.59% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 17.08% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 25.64% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -11.30% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 1.23% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 5.44% |
| 10 | Welsis | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -613.25% |
| Sep 30, 2023 | 2.77% |
| Jun 30, 2023 | -60.64% |
| Dec 31, 2022 | -263.17% |